Patents by Inventor Donald Joseph Philip Pinto

Donald Joseph Philip Pinto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
    Patent number: 6998408
    Abstract: The present application describes 6–5, 6—6, or 6–7 heterobicycles of Formula I or pharmaceutically acceptable salt forms thereof: wherein ring P is a 6-membered heteroaromatic and ring M is a 5-, 6-, or 7-membered non-aromatic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: February 14, 2006
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventor: Donald Joseph Philip Pinto
  • 5-6 to 5-7 Heterobicycles as factor Xa inhibitors
    Patent number: 6960595
    Abstract: The present application describes 5-6 or 5-7 heterobicyclics of Formula I: or pharmaceutically acceptable salt forms thereof, wherein ring P is a 5-membered heteroaromatic and ring M is a 6 or 7-membered non-aromatic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: November 1, 2005
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Donald Joseph Philip Pinto, Renhua Li
  • 1,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitors
    Patent number: 6750225
    Abstract: The present application describes 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones of the following formula or pharmaceutically acceptable salt forms thereof: wherein ring Rb is 3-amido or 4-methoxy, Ra can be cyano, trifluoromethyl, or amido, and R can be a substituted phenyl, a substituted imidazolyl, or a substituted pyridine. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
    Type: Grant
    Filed: April 17, 2002
    Date of Patent: June 15, 2004
    Assignee: Bristol-Myers Squibb Pharms Company
    Inventors: Donald Joseph Philip Pinto, Robert Anthony Galemmo, Jr., Michael James Orwat, Mimi Lifen Quan
  • 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor Xa inhibitors
    Patent number: 6706730
    Abstract: The present application describes 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones of Formula I or pharmaceutically acceptable salt forms thereof: wherein ring R is 3-amido or 4-methoxy, R1 is trifluoromethyl or amido, and R2 is aminomethyl, N-methylaminomethyl, and N,N-dimethylaminomethyl. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
    Type: Grant
    Filed: April 17, 2002
    Date of Patent: March 16, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventor: Donald Joseph Philip Pinto
  • 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor Xa inhibitors
    Publication number: 20030022916
    Abstract: The present application describes 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones of Formula I or pharmaceutically acceptable salt forms thereof: 1
    Type: Application
    Filed: April 17, 2002
    Publication date: January 30, 2003
    Inventors: Donald Joseph Philip Pinto, Robert Anthony Galemmo
  • 5-6 or 5-7 Heterobicycles as Factor Xa inhibitors
    Publication number: 20030018023
    Abstract: The present application describes 5-6 or 5-7 heterobicyclics of Formula I: 1
    Type: Application
    Filed: March 25, 2002
    Publication date: January 23, 2003
    Inventors: Donald Joseph Philip Pinto, Renhua Li
  • 1,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitors
    Publication number: 20020177713
    Abstract: The present application describes 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones of the following formula or pharmaceutically acceptable salt forms thereof: 1
    Type: Application
    Filed: April 17, 2002
    Publication date: November 28, 2002
    Inventors: Donald Joseph Philip Pinto, Robert Anthony Galemmo, Michael James Orwat, Mimi Lifen Quan